143 related articles for article (PubMed ID: 19002391)
21. Thrombotic complications of polycythemia vera.
Varma S; Sharma A; Malhotra P; Kumari S; Jain S; Varma N
Hematology; 2008 Dec; 13(6):319-23. PubMed ID: 19055858
[TBL] [Abstract][Full Text] [Related]
22. The impact of peripheral blood values and bone marrow findings on prognosis for patients with essential thrombocythemia and polycythemia vera.
Abdulkarim K; Ridell B; Johansson P; Kutti J; Safai-Kutti S; Andréasson B
Eur J Haematol; 2011 Feb; 86(2):148-55. PubMed ID: 21059102
[TBL] [Abstract][Full Text] [Related]
23. [Clinical analysis of 185 patients with polycythemia vera].
Bai J; Shao Z; Jing L; Liu H; Shi J; Zhao M; Fu R; He G; Sun J; Jia H; Qian L; Yang T; Yang C
Zhonghua Xue Ye Xue Za Zhi; 2002 Nov; 23(11):578-80. PubMed ID: 12482341
[TBL] [Abstract][Full Text] [Related]
24. Long term follow up of 93 families with myeloproliferative neoplasms: life expectancy and implications of JAK2V617F in the occurrence of complications.
Malak S; Labopin M; Saint-Martin C; Bellanne-Chantelot C; Najman A;
Blood Cells Mol Dis; 2012 Oct 15-Dec 15; 49(3-4):170-6. PubMed ID: 22818858
[TBL] [Abstract][Full Text] [Related]
25. Leucocytosis and thrombosis at diagnosis are associated with poor survival in polycythaemia vera: a population-based study of 327 patients.
Bonicelli G; Abdulkarim K; Mounier M; Johansson P; Rossi C; Jooste V; Andreasson B; Maynadié M; Girodon F
Br J Haematol; 2013 Jan; 160(2):251-4. PubMed ID: 23151052
[TBL] [Abstract][Full Text] [Related]
26. Natural history of polycythemia vera and essential thrombocythemia presenting with splanchnic vein thrombosis.
Alvarez-Larrán A; Pereira A; Magaz M; Hernández-Boluda JC; Garrote M; Cuevas B; Ferrer-Marín F; Gómez-Casares MT; García-Gutiérrez V; Mata-Vázquez MI; Turon F; Hernandez-Gea V; Arellano-Rodrigo E; Cervantes F; García-Pagán JC;
Ann Hematol; 2020 Apr; 99(4):791-798. PubMed ID: 32086587
[TBL] [Abstract][Full Text] [Related]
27. Prediction of thrombotic and hemorrhagic events during polycythemia vera or essential thrombocythemia based on leukocyte burden.
Lim Y; Lee JO; Kim SH; Kim JW; Kim YJ; Lee KW; Lee JS; Bang SM
Thromb Res; 2015 May; 135(5):846-51. PubMed ID: 25743883
[TBL] [Abstract][Full Text] [Related]
28. Postpolycythemia myeloid metaplasia.
Silverstein MN
Arch Intern Med; 1974 Jul; 134(1):113-7. PubMed ID: 4833938
[No Abstract] [Full Text] [Related]
29. Leukemic transformation in myeloproliferative neoplasms: therapy-related or unrelated?
Björkholm M; Hultcrantz M; Derolf ÅR
Best Pract Res Clin Haematol; 2014 Jun; 27(2):141-53. PubMed ID: 25189725
[TBL] [Abstract][Full Text] [Related]
30. Elevated White Blood Cell Levels and Thrombotic Events in Patients With Polycythemia Vera: A Real-World Analysis of Veterans Health Administration Data.
Parasuraman S; Yu J; Paranagama D; Shrestha S; Wang L; Baser O; Scherber R
Clin Lymphoma Myeloma Leuk; 2020 Feb; 20(2):63-69. PubMed ID: 31865003
[TBL] [Abstract][Full Text] [Related]
31. Impact of comorbidities and body mass index on the outcome of polycythemia vera patients.
Benevolo G; Elli EM; Bartoletti D; Latagliata R; Tiribelli M; Heidel FH; Cavazzini F; Bonifacio M; Crugnola M; Binotto G; D'Addio A; Tieghi A; Bergamaschi M; Caocci G; Polverelli N; Bossi E; Auteri G; Carmosino I; Catani L; Cuneo A; Krampera M; Lanza F; Lemoli RM; Vianelli N; Breccia M; Palumbo GA; Cavo M; Palandri F
Hematol Oncol; 2021 Aug; 39(3):409-418. PubMed ID: 33590502
[TBL] [Abstract][Full Text] [Related]
32. Clinical outcomes under hydroxyurea treatment in polycythemia vera: a systematic review and meta-analysis.
Ferrari A; Carobbio A; Masciulli A; Ghirardi A; Finazzi G; De Stefano V; Vannucchi AM; Barbui T
Haematologica; 2019 Dec; 104(12):2391-2399. PubMed ID: 31123026
[TBL] [Abstract][Full Text] [Related]
33. The 'spent' phase of polycythaemia vera: hypersplenism in the absence of myelofibrosis.
Najean Y; Arrago JP; Rain JD; Dresch C
Br J Haematol; 1984 Jan; 56(1):163-70. PubMed ID: 6584168
[TBL] [Abstract][Full Text] [Related]
34. Circulating erythroid progenitors in patients with 'spent' polycythaemia vera and myelofibrosis with myeloid metaplasia.
Kornberg A; Fibach E; Treves A; Goldfarb A; Rachmilewitz EA
Br J Haematol; 1982 Dec; 52(4):573-8. PubMed ID: 7138787
[TBL] [Abstract][Full Text] [Related]
35. Evaluation of the need for cytoreduction and its potential carcinogenicity in children and young adults with myeloproliferative neoplasms.
Choi HS; Hong J; Hwang SM; Lee JH; Ma Y; Kim SA; Lee JY; Lee JO; Bang SM
Ann Hematol; 2021 Oct; 100(10):2567-2574. PubMed ID: 34331110
[TBL] [Abstract][Full Text] [Related]
36. JAK2 exon 12 mutated polycythemia vera: Mayo-Careggi MPN Alliance study of 33 consecutive cases and comparison with JAK2V617F mutated disease.
Tefferi A; Lavu S; Mudireddy M; Lasho TL; Finke CM; Gangat N; Pardanani A; Hanson CA; Mannarelli C; Guglielmelli P; Vannucchi AM
Am J Hematol; 2018 Aug; 93(4):E93-E96. PubMed ID: 29274140
[No Abstract] [Full Text] [Related]
37. Low-risk polycythemia vera treated with phlebotomies: clinical characteristics, hematologic control and complications in 453 patients from the Spanish Registry of Polycythemia Vera.
Triguero A; Pedraza A; Pérez-Encinas M; Mata-Vázquez MI; Vélez P; Fox L; Gómez-Calafat M; García-Delgado R; Gasior M; Ferrer-Marín F; García-Gutiérrez V; Angona A; Gómez-Casares MT; Cuevas B; Martínez C; Pérez R; Raya JM; Guerrero L; Murillo I; Bellosillo B; Hernández-Boluda JC; Sanz C; Álvarez-Larrán A;
Ann Hematol; 2022 Oct; 101(10):2231-2239. PubMed ID: 36042023
[TBL] [Abstract][Full Text] [Related]
38. Polycythemia vera and essential thrombocythemia: 2015 update on diagnosis, risk-stratification and management.
Tefferi A; Barbui T
Am J Hematol; 2015 Feb; 90(2):162-73. PubMed ID: 25611051
[TBL] [Abstract][Full Text] [Related]
39. Presence of unfavorable cytogenetic abnormalities is the strongest predictor of poor survival in secondary myelofibrosis.
Dingli D; Schwager SM; Mesa RA; Li CY; Dewald GW; Tefferi A
Cancer; 2006 May; 106(9):1985-9. PubMed ID: 16568439
[TBL] [Abstract][Full Text] [Related]
40. Efficacy trial of pipobroman in polycythemia vera and incidence of acute leukemia.
Brusamolino E; Salvaneschi L; Canevari A; Bernasconi C
J Clin Oncol; 1984 Jun; 2(6):558-61. PubMed ID: 6374054
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
